Publications by authors named "J E C Boey"
To understand differences in anti-factor-Xa levels produced by two different dosing strategies (conventional and individualized) for therapeutic enoxaparin in a cohort of hospital inpatients. A multicenter, retrospective cohort study over a two- and a half-year period for inpatients with stable renal function and on therapeutic enoxaparin. Anti-factor-Xa levels were taken 3-5 h after enoxaparin administration and a minimum of 48 h of dosing.
View Article and Find Full Text PDFNecrotising soft tissue infections (NSTIs) are one of the most challenging and severe forms of infections. The prognosis requires accurate and aggressive diagnosis and management. In this case, we present an unexplained case of concurrence of TE events following BKA for the surgical management of NSTI.
View Article and Find Full Text PDFBackground: Ankle osteoarthritis affects 1-3 % of all adults. Contemporary evidence is equivocal when comparing the outcomes and complications of TAA and AA. This review aims to compare the complications between TAA and AA to provide surgeons with an additional perspective when managing ESAO.
View Article and Find Full Text PDFBackground: There is a lack of evidence regarding direct oral anticoagulant (DOAC) assay plasma concentrations and their association with bleeding events or transfusion requirements. This multicenter study aimed to characterize the use and plasma levels of DOAC assays of anticoagulated patients who present to emergency with a bleeding event and their association with bleeding severity.
Methods: A multicenter retrospective cohort study of consecutive emergency bleeding presentations with a DOAC assay over a five-year period was conducted.
Article Synopsis
- Hyaluronidase is the primary treatment for skin necrosis caused by vascular occlusion after hyaluronic acid fillers, but there’s a lack of strong evidence on the best dosages to use.
- A systematic review and pilot meta-analysis of 15 studies found that 77.8% of patients saw complete resolution of scars after treatment, with low doses showing a higher success rate (88.1%) compared to high doses (69.6%), although the difference was not statistically significant.
- The study suggests that future research should focus on providing detailed protocols to create evidence-based guidelines for using hyaluronidase in clinical settings.